| Name | Type | |
|---|
| |
| Peer to peer network | Expiration Reminder | |
| |
| Peer to peer network | Prior Art | |
| |
| Peer to peer network | Comment | |
| |
| Preserving privacy of data streams using dynamic correlations | Expiration Reminder | |
| |
| Preserving privacy of data streams using dynamic correlations | Prior Art | |
| |
| Preserving privacy of data streams using dynamic correlations | Comment | |
| |
| ORGANIC COMPOUNDS -- PART OF THE CLASS 532-570 SERIES | Patent Class | |
| |
| ORGANIC COMPOUNDS -- PART OF THE CLASS 532-570 SERIES | Patent Class | |
| |
| DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS | Patent Class | |
| |
| CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | Patent Class | |
| |
| DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS | Patent Class | |
| |
| ORGANIC COMPOUNDS -- PART OF THE CLASS 532-570 SERIES | Patent Class | |
| |
| Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates | Prior Art | |
| |
| Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates | Comment | |
| |
| Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates | Expiration Reminder | |
| |
| Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase | Prior Art | |
| |
| Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase | Comment | |
| |
| Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase | Expiration Reminder | |
| |
| Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorptioin through modulation of nf-kb | Prior Art | |
| |
| Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorptioin through modulation of nf-kb | Comment | |
| |
| Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorptioin through modulation of nf-kb | Expiration Reminder | |
| |
| Niacin-based pharmaceutical compositions | Prior Art | |
| |
| Niacin-based pharmaceutical compositions | Comment | |
| |
| Niacin-based pharmaceutical compositions | Expiration Reminder | |
| |
| Skin compositions containing hydrocortisone | Prior Art | |
| |
| Skin compositions containing hydrocortisone | Comment | |
| |
| Skin compositions containing hydrocortisone | Expiration Reminder | |
| |
| Treatment of ischemic episodes and cerebroprotection through prostaglandin e2 (pge2) ep2 and/or ep4 receptor agonists | Prior Art | |
| |
| Treatment of ischemic episodes and cerebroprotection through prostaglandin e2 (pge2) ep2 and/or ep4 receptor agonists | Comment | |
| |
| Treatment of ischemic episodes and cerebroprotection through prostaglandin e2 (pge2) ep2 and/or ep4 receptor agonists | Expiration Reminder | |
| |
| Process for preparing 2-alkyl-3-halo-6-nitrilpyridine and its carboxylic acid and ester derivatives | Prior Art | |
| |
| Process for preparing 2-alkyl-3-halo-6-nitrilpyridine and its carboxylic acid and ester derivatives | Comment | |
| |
| Process for preparing 2-alkyl-3-halo-6-nitrilpyridine and its carboxylic acid and ester derivatives | Expiration Reminder | |
| |
| Methods of treating hypertriglyceridemia | Prior Art | |
| |
| Methods of treating hypertriglyceridemia | Comment | |
| |
| Methods of treating hypertriglyceridemia | Expiration Reminder | |
| |
| Inhibitors of fatty acid uptake and methods of use | Prior Art | |
| |
| Inhibitors of fatty acid uptake and methods of use | Comment | |
| |
| Inhibitors of fatty acid uptake and methods of use | Expiration Reminder | |
| |
| Set of geldanamycin derivatives and their preparation methods | Prior Art | |
| |
| Set of geldanamycin derivatives and their preparation methods | Comment | |
| |
| Set of geldanamycin derivatives and their preparation methods | Expiration Reminder | |
| |
